Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $2.65 billion. The enterprise value is $2.29 billion.
| Market Cap | 2.65B |
| Enterprise Value | 2.29B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 95.22 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Shares Outstanding | 95.22M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 6.24% |
| Owned by Institutions (%) | 105.22% |
| Float | 82.46M |
Valuation Ratios
The trailing PE ratio is 44.82 and the forward PE ratio is 34.93.
| PE Ratio | 44.82 |
| Forward PE | 34.93 |
| PS Ratio | 2.39 |
| Forward PS | 2.02 |
| PB Ratio | 4.63 |
| P/FCF Ratio | 13.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.06, with an EV/FCF ratio of 12.04.
| EV / Earnings | 37.40 |
| EV / Sales | 2.07 |
| EV / EBITDA | 30.06 |
| EV / EBIT | 31.06 |
| EV / FCF | 12.04 |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.31 |
| Quick Ratio | 3.25 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.09 |
| Interest Coverage | -23.69 |
Financial Efficiency
Return on equity (ROE) is 11.60% and return on invested capital (ROIC) is 8.90%.
| Return on Equity (ROE) | 11.60% |
| Return on Assets (ROA) | 8.30% |
| Return on Capital (ROIC) | 8.90% |
| Revenue Per Employee | $1.96M |
| Profits Per Employee | $108,228 |
| Employee Count | 566 |
| Asset Turnover | 1.50 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $15.62 million in taxes.
| Income Tax | 15.62M |
| Effective Tax Rate | 20.32% |
Stock Price Statistics
The stock price has decreased by -30.91% in the last 52 weeks. The beta is 1.46, so Progyny's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -30.91% |
| 50-Day Moving Average | 27.76 |
| 200-Day Moving Average | 33.42 |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 1,051,700 |
Short Selling Information
The latest short interest is 7.57 million, so 7.95% of the outstanding shares have been sold short.
| Short Interest | 7.57M |
| Short Previous Month | 7.54M |
| Short % of Shares Out | 7.95% |
| Short % of Float | 9.18% |
| Short Ratio (days to cover) | 6.93 |
Income Statement
In the last 12 months, Progyny had revenue of $1.11 billion and earned $61.26 million in profits. Earnings per share was $0.62.
| Revenue | 1.11B |
| Gross Profit | 242.57M |
| Operating Income | 65.70M |
| Pretax Income | 76.88M |
| Net Income | 61.26M |
| EBITDA | 76.22M |
| EBIT | 73.76M |
| Earnings Per Share (EPS) | $0.62 |
Balance Sheet
The company has $371.83 million in cash and $16.78 million in debt, giving a net cash position of $355.05 million or $3.73 per share.
| Cash & Cash Equivalents | 371.83M |
| Total Debt | 16.78M |
| Net Cash | 355.05M |
| Net Cash Per Share | $3.73 |
| Equity (Book Value) | 571.60M |
| Book Value Per Share | 6.00 |
| Working Capital | 475.59M |
Cash Flow
In the last 12 months, operating cash flow was $193.59 million and capital expenditures -$3.24 million, giving a free cash flow of $190.34 million.
| Operating Cash Flow | 193.59M |
| Capital Expenditures | -3.24M |
| Free Cash Flow | 190.34M |
| FCF Per Share | $1.97 |
Margins
Gross margin is 21.89%, with operating and profit margins of 5.93% and 5.53%.
| Gross Margin | 21.89% |
| Operating Margin | 5.93% |
| Pretax Margin | 6.94% |
| Profit Margin | 5.53% |
| EBITDA Margin | 6.88% |
| EBIT Margin | 6.66% |
| FCF Margin | 17.17% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | 2.31% |
| FCF Yield | 7.19% |
Analyst Forecast
The average price target for Progyny is $43.57, which is 56.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $43.57 |
| Price Target Difference | 56.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 17.44% |
| EPS Growth Forecast (5Y) | 40.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 9.74 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.74 |
| Piotroski F-Score | 6 |